Frank Muehlenbeck
Member
Curetis
Germany
Biography
Dr. Frank Muehlenbeck is Member of the Supervisory Board of Curetis BV. He is a Partner at EMBL Ventures, a Heidelberg based VC fund since October of 2015. Previously Dr. Muehlenbeck managed the healthcare business of aeris CAPITAL (2006-2015), a private investment office advising high-net-worth individuals. At aeris CAPITAL, Dr. Muehlenbeck has been responsible for investments in life science companies. He previously worked at firstVentury Equity GmbH, a venture capital company in Heidelberg, and Steinbeis, a technology transfer institution in Germany. At Steinbeis he founded the Steinbeis Transfer Center Biotech-Consult in 2001, a profit center within a franchise network. Investments where Dr. Muehlenbeck served or serves on the board include US based IonTorrent (investment in 2009, sold to Life Technologies in 2010), Heidelberg based Affimed (investment in 2001, IPO on NASDAQ in 2014, on the board until 2015; co-investors Orbimed, Life Science Partners, BiomedInvest, NovoNordisk and others), ConformMIS Inc. (investment 2004, board position since 2009, IPO on NASDAQ in 2015) and Sonetik AG (Switzerland – board position (Verwaltungsrat) since 2014). Previous board positions included privately held companies Solstice LLC (drug development company in California), Loser Medizintechnik GmbH (medtech company in Leipzig), Tuebingen Scientific GmbH (medtech company in Tubingen) and Amphivena Therapeutics Inc (drug development company in California). From 2009 to 2015 Dr. Muehlenbeck served as chairman of the supervisory board at Curetis AG. Dr. Muehlenbeck holds a lectureship at Karlsruhe university for commercial aspects of biotechnology. He studied Technical Biology at Stuttgart University and holds a Doctorate in Cell Biology. He is Member of the Nominating and Remuneration Committees of the Company.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
